Loncar China BioPharma ETF (CHNA) is a publicly traded company in the Financial Services sector, operating within the Asset Management industry.
CHNA has IPO date of 2018-08-15, listed on the NASDAQ Global Market.
The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.
